• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY Back to Search Results
Catalog Number SCF10X25AGEN
Device Problems Patient-Device Incompatibility (2682); Appropriate Term/Code Not Available (3191)
Patient Problems Cellulitis (1768); Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
Medwatch sent to fda on 09/08/2016.The device has been discarded and will not be returned.Therefore, no analysis or testing will be done.The events of infection, cellulitis, "a ¿pinhole¿ on the underside of the breast through which the seri® was visible", and inadequate tissue ingrowth are physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.Device labeling addresses the reported event of infection as follows: "adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion.".
 
Event Description
Physician reported the patient underwent bilateral reconstruction revision on (b)(6) 2015 during which time style 20 silicone gel breast implants were placed.A single piece of seri® scaffold was placed bilaterally at that time; 10 x 23 cm on the right side in the inframammary to lateral breast border position and 6 x 2 cm on the left side in a triangular shape to assist with a thin capsule following radiation therapy.Seri® was dipped in saline prior to implantation and the surgical site was irrigated with triple antibiotic.On an unspecified date, the patient experienced an infection, was hospitalized, and given antibiotics via iv.On (b)(6) 2016, the right side seri® and concomitantly placed breast implant were removed due to infection which was later clarified to be cellulitis.Approximately 75% of the right side seri® was unincorporated.On (b)(6) 2016, the left side seri® and concomitantly placed breast implant were also removed due to a staph infection.Physician additionally found there to be a ¿pinhole¿ on the underside of the breast through which the seri® and breast implant were visible.100% of the left side seri® was unincorporated.Physician stated that 100% of the seri® scaffold was removed from both sides.All explanted devices have been discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SERI SURGICAL SCAFFOLD (US)
Type of Device
MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY
Manufacturer (Section D)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer (Section G)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key5935419
MDR Text Key54153530
Report Number8020862-2016-00043
Device Sequence Number1
Product Code OXF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123128
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2017
Device Catalogue NumberSCF10X25AGEN
Device Lot NumberP13101601A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/10/2016
Initial Date FDA Received09/08/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/28/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
STYLE 20 SILICONE BREAST IMPLANT (B)(6) 2015
Patient Outcome(s) Hospitalization; Required Intervention;
-
-